Nutex Health (NASDAQ:NUTX) Releases Earnings Results, Misses Estimates By $3.95 EPS

Nutex Health (NASDAQ:NUTX) announced its earnings results on Thursday. The company reported $1.61 EPS for the quarter, missing the consensus estimate of $5.56 by ($3.95), Zacks reports. The business had revenue of $151.68 million during the quarter, compared to analyst estimates of $258.82 million. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.

Nutex Health Trading Down 11.2%

Shares of NUTX traded down $11.83 during trading hours on Friday, hitting $93.51. 382,361 shares of the stock traded hands, compared to its average volume of 197,719. The business has a fifty day moving average of $138.40 and a 200-day moving average of $124.53. The firm has a market capitalization of $661.12 million, a PE ratio of 5.06 and a beta of 0.03. Nutex Health has a 1-year low of $40.67 and a 1-year high of $193.07. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Topline Capital Management LLC lifted its holdings in Nutex Health by 72.0% during the second quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after acquiring an additional 129,418 shares in the last quarter. Millennium Management LLC raised its position in shares of Nutex Health by 191.1% during the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after purchasing an additional 61,308 shares during the period. Pertento Partners LLP lifted its holdings in shares of Nutex Health by 20.0% during the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after purchasing an additional 54,001 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Nutex Health by 12.7% in the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock valued at $22,209,000 after purchasing an additional 24,275 shares during the period. Finally, UBS Group AG boosted its stake in Nutex Health by 51.3% in the 3rd quarter. UBS Group AG now owns 68,791 shares of the company’s stock worth $7,107,000 after purchasing an additional 23,316 shares during the period. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research note on Monday, December 29th. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.